US Stock MarketDetailed Quotes

Apyx Medical (APYX)

Watchlist
  • 3.985
  • +0.095+2.44%
Trading Jan 16 13:40 ET
163.50MMarket Cap-11.07P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Apyx Medical (APYX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.36%-3.54M
71.52%-1.23M
88.93%-702K
-243.82%-18.05M
-32.78%-2.94M
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
74.12%-5.25M
51.17%-2.21M
Net income from continuing operations
58.62%-1.96M
43.24%-3.74M
45.03%-4.17M
-24.98%-23.56M
51.59%-4.66M
-1.05%-4.72M
-546.32%-6.59M
-114.89%-7.59M
19.02%-18.85M
-58.68%-9.62M
Operating gains losses
----
----
----
-97.67%13K
-101.09%-35K
-22.22%28K
--0
--20K
642.67%557K
321,400.00%3.21M
Depreciation and amortization
13.89%164K
-15.38%132K
-12.10%138K
-13.44%599K
-6.58%142K
-22.58%144K
3.31%156K
-22.66%157K
-22.25%692K
-24.75%152K
Other non cash items
5.22%262K
2.77%260K
3.17%260K
100.79%1.27M
131.98%515K
39.11%249K
54.27%253K
276.12%252K
--632K
--222K
Change In working capital
-119.98%-2.72M
84.71%1.29M
923.17%2.59M
-122.46%-1.25M
-117.49%-394K
-119.17%-1.24M
121.13%700K
-301.92%-315K
206.25%5.54M
637.71%2.25M
-Change in receivables
-496.10%-1.84M
261.86%471K
166.71%3.94M
-151.25%-2.04M
-110.85%-2.91M
-104.40%-308K
87.23%-291K
134.60%1.48M
97.07%3.97M
-1.99%-1.38M
-Change in inventory
-343.66%-865K
-227.38%-521K
-244.20%-199K
55.11%2.26M
28.64%1.36M
366.92%355K
218.55%409K
-84.30%138K
126.20%1.46M
917.31%1.06M
-Change in prepaid assets
-242.74%-425K
-6.59%397K
-84.65%37K
555.85%857K
-38.24%315K
80.66%-124K
146.45%425K
-71.91%241K
64.05%-188K
25,600.00%510K
-Change in payables and accrued expense
135.12%407K
502.55%946K
45.35%-1.19M
-874.09%-2.33M
-59.17%844K
-626.82%-1.16M
-30.22%157K
1.76%-2.17M
126.38%301K
147.84%2.07M
Cash from discontinued investing activities
Operating cash flow
20.36%-3.54M
71.52%-1.23M
88.93%-702K
-243.82%-18.05M
-32.78%-2.94M
-220.13%-4.44M
10.78%-4.33M
-237.11%-6.34M
74.12%-5.25M
51.17%-2.21M
Investing cash flow
Cash flow from continuing investing activities
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
Net PPE purchase and sale
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
Cash from discontinued investing activities
Investing cash flow
-239.22%-519K
8.30%-265K
-57.14%-55K
-110.72%-722K
-163.44%-245K
12.07%-153K
-104.06%-289K
68.18%-35K
766.73%6.73M
34.51%-93K
Financing cash flow
Cash flow from continuing financing activities
1,000.00%45K
600.00%25K
600.00%25K
-79.03%6.75M
-71.65%6.76M
-103.05%-5K
-110.87%-5K
-100.06%-5K
14,723.04%32.17M
238,540.00%23.84M
Net issuance payments of debt
20.00%-4K
0.00%-5K
0.00%-5K
-100.06%-20K
-100.02%-5K
99.17%-5K
50.00%-5K
-100.05%-5K
23,775.00%35.04M
257,920.00%25.78M
Net common stock issuance
----
----
----
--7M
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
----
----
-76.44%86K
---586K
Net other financing activities
--0
--30K
--30K
92.06%-235K
----
----
----
----
---2.96M
---1.35M
Cash from discontinued financing activities
Financing cash flow
1,000.00%45K
600.00%25K
600.00%25K
-79.03%6.75M
-71.65%6.76M
-103.05%-5K
-110.87%-5K
-100.06%-5K
14,723.04%32.17M
238,540.00%23.84M
Net cash flow
Beginning cash position
-10.33%29.3M
-16.82%31.01M
-27.29%31.74M
328.30%43.65M
26.56%28.01M
76.84%32.68M
129.36%37.28M
328.30%43.65M
-66.98%10.19M
49.22%22.13M
Current changes in cash
12.79%-4.01M
68.14%-1.47M
88.53%-732K
-135.73%-12.02M
-83.39%3.58M
-224.74%-4.6M
-300.56%-4.62M
-204.25%-6.38M
259.69%33.65M
560.04%21.54M
Effect of exchange rate changes
-132.84%-156K
-1,347.37%-237K
-81.82%2K
159.16%113K
814.29%150K
-116.13%-67K
123.46%19K
118.97%11K
-148.35%-191K
-151.22%-21K
End cash Position
-10.27%25.14M
-10.33%29.3M
-16.82%31.01M
-27.29%31.74M
-27.29%31.74M
26.56%28.01M
76.84%32.68M
129.36%37.28M
328.30%43.65M
328.30%43.65M
Free cash flow
11.71%-4.06M
67.56%-1.5M
88.13%-757K
-224.61%-18.77M
-38.05%-3.18M
-230.41%-4.59M
7.79%-4.62M
-220.24%-6.38M
72.84%-5.78M
50.66%-2.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.36%-3.54M71.52%-1.23M88.93%-702K-243.82%-18.05M-32.78%-2.94M-220.13%-4.44M10.78%-4.33M-237.11%-6.34M74.12%-5.25M51.17%-2.21M
Net income from continuing operations 58.62%-1.96M43.24%-3.74M45.03%-4.17M-24.98%-23.56M51.59%-4.66M-1.05%-4.72M-546.32%-6.59M-114.89%-7.59M19.02%-18.85M-58.68%-9.62M
Operating gains losses -------------97.67%13K-101.09%-35K-22.22%28K--0--20K642.67%557K321,400.00%3.21M
Depreciation and amortization 13.89%164K-15.38%132K-12.10%138K-13.44%599K-6.58%142K-22.58%144K3.31%156K-22.66%157K-22.25%692K-24.75%152K
Other non cash items 5.22%262K2.77%260K3.17%260K100.79%1.27M131.98%515K39.11%249K54.27%253K276.12%252K--632K--222K
Change In working capital -119.98%-2.72M84.71%1.29M923.17%2.59M-122.46%-1.25M-117.49%-394K-119.17%-1.24M121.13%700K-301.92%-315K206.25%5.54M637.71%2.25M
-Change in receivables -496.10%-1.84M261.86%471K166.71%3.94M-151.25%-2.04M-110.85%-2.91M-104.40%-308K87.23%-291K134.60%1.48M97.07%3.97M-1.99%-1.38M
-Change in inventory -343.66%-865K-227.38%-521K-244.20%-199K55.11%2.26M28.64%1.36M366.92%355K218.55%409K-84.30%138K126.20%1.46M917.31%1.06M
-Change in prepaid assets -242.74%-425K-6.59%397K-84.65%37K555.85%857K-38.24%315K80.66%-124K146.45%425K-71.91%241K64.05%-188K25,600.00%510K
-Change in payables and accrued expense 135.12%407K502.55%946K45.35%-1.19M-874.09%-2.33M-59.17%844K-626.82%-1.16M-30.22%157K1.76%-2.17M126.38%301K147.84%2.07M
Cash from discontinued investing activities
Operating cash flow 20.36%-3.54M71.52%-1.23M88.93%-702K-243.82%-18.05M-32.78%-2.94M-220.13%-4.44M10.78%-4.33M-237.11%-6.34M74.12%-5.25M51.17%-2.21M
Investing cash flow
Cash flow from continuing investing activities -239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K
Net PPE purchase and sale -239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K
Cash from discontinued investing activities
Investing cash flow -239.22%-519K8.30%-265K-57.14%-55K-110.72%-722K-163.44%-245K12.07%-153K-104.06%-289K68.18%-35K766.73%6.73M34.51%-93K
Financing cash flow
Cash flow from continuing financing activities 1,000.00%45K600.00%25K600.00%25K-79.03%6.75M-71.65%6.76M-103.05%-5K-110.87%-5K-100.06%-5K14,723.04%32.17M238,540.00%23.84M
Net issuance payments of debt 20.00%-4K0.00%-5K0.00%-5K-100.06%-20K-100.02%-5K99.17%-5K50.00%-5K-100.05%-5K23,775.00%35.04M257,920.00%25.78M
Net common stock issuance --------------7M------------------0----
Proceeds from stock option exercised by employees --------------0--0--0---------76.44%86K---586K
Net other financing activities --0--30K--30K92.06%-235K-------------------2.96M---1.35M
Cash from discontinued financing activities
Financing cash flow 1,000.00%45K600.00%25K600.00%25K-79.03%6.75M-71.65%6.76M-103.05%-5K-110.87%-5K-100.06%-5K14,723.04%32.17M238,540.00%23.84M
Net cash flow
Beginning cash position -10.33%29.3M-16.82%31.01M-27.29%31.74M328.30%43.65M26.56%28.01M76.84%32.68M129.36%37.28M328.30%43.65M-66.98%10.19M49.22%22.13M
Current changes in cash 12.79%-4.01M68.14%-1.47M88.53%-732K-135.73%-12.02M-83.39%3.58M-224.74%-4.6M-300.56%-4.62M-204.25%-6.38M259.69%33.65M560.04%21.54M
Effect of exchange rate changes -132.84%-156K-1,347.37%-237K-81.82%2K159.16%113K814.29%150K-116.13%-67K123.46%19K118.97%11K-148.35%-191K-151.22%-21K
End cash Position -10.27%25.14M-10.33%29.3M-16.82%31.01M-27.29%31.74M-27.29%31.74M26.56%28.01M76.84%32.68M129.36%37.28M328.30%43.65M328.30%43.65M
Free cash flow 11.71%-4.06M67.56%-1.5M88.13%-757K-224.61%-18.77M-38.05%-3.18M-230.41%-4.59M7.79%-4.62M-220.24%-6.38M72.84%-5.78M50.66%-2.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.35%
Sample Name
Sample Code
 +3.42%
Sample Name
Sample Code
 +3.28%
4
Clean Energy Fuels
CLNE
+1.59%
5
Block
XYZ
+1.49%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +10.32%
Sample Name
Sample Code
 +10.17%
Sample Name
Sample Code
 +9.51%
4
Kingsoft Cloud
KC
+7.12%
5
United Microelectronics
UMC
+6.26%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -